Francine S Grant

This inventor holds 38 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent, primarily in Leukocyte Adhesion Inhibition. Top assignees: Elan Pharmaceuticals, Inc., Wyeth, Other. Active years: 1996-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francine S Grant. Retrieved from https://idiyas.com/inventor/francine-s-grant

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38

% Patents Active = 39.5

CIPO Patents = 1 (Patent Applications = 8)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 7.8

ph-index = 11

Forward Citations = 356(Granted Patents)

Location History:

South San Francisco, CA (US) (1996)
Bellevue, WA (US) (2006)
San Carlos, CA (US) (2004 - 2007)
San Francisco, CA (US) (2001 - 2008)
Milpitas, CA (US) (2002 - 2008)
Mercer Island, WA (US) (2006 - 2011)

Company Filing History:

21 out of 202

Elan Pharmaceuticals, Inc.

16 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2011

Loading Chart...

Areas of Expertise:

Heteroaryl Compounds

Heterocyclic Compounds

Aryl Compounds

Leukocyte Adhesion

VLA-4 Inhibitors

Bradykinin Antagonists

Dipeptide Derivatives

Multicyclic Compounds

Alpha 4 Integrin Inhibitors

Sulfonylquinoxalone Derivatives

Carbamyloxy Compounds

Beta-Amino Acid Derivatives

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7973044 - Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 (2011-07-05),

2. 7968547 - Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 (2011-06-28),

3. 7635775 - Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists (2009-12-22),

4. 7452912 - Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 (2008-11-18),

5. 7378529 - Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 (2008-05-27),

6. 7320960 - Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 (2008-01-22),

7. 7291645 - Phenylalanine derivatives as alpha 4 integrin inhibitors (2007-11-06),

8. 7288526 - Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4 (2007-10-30),

9. 7229970 - Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 (2007-06-12),

10. 7223762 - Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 (2007-05-29),

11. 7183281 - Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists (2007-02-27),

12. 7166580 - Compounds which inhibit leukocyte adhesion mediated by VLA-4 (2007-01-23),

13. 7115768 - Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 (2006-10-03),

14. 7074783 - Sulfonylbenzodiazepinone acetamides as bradykinin antagonists (2006-07-11),

15. 7056937 - Sulfonylquinoxalone derivatives as bradykinin antagonists (2006-06-06),

Title: The Innovative Journey of Francine S Grant

Introduction: Francine S Grant, a pioneering inventor based in Milpitas, CA, has made significant contributions to the world of technology through her groundbreaking innovations.

Latest Patents: Francine's latest patents focus on advancements in renewable energy technologies, particularly in the field of solar power storage systems.

Career Highlights: With a career spanning over two decades, Francine has established herself as a leading figure in the renewable energy sector. Her work has been instrumental in driving forward the development of sustainable energy solutions.

Collaborations: Throughout her career, Francine has collaborated with top research institutions and universities to further her research and bring her inventions to life. Her partnerships have led to the successful implementation of several cutting-edge technologies in the market.

Conclusion: Francine S Grant's dedication to innovation and sustainability has not only shaped the renewable energy landscape but has also inspired a new generation of inventors to push the boundaries of what is possible in the field.

Profile summary based on public USPTO records.